H. Lundbeck A/s

This study aimed to check the long-term safety of a migraine prevention medicine called eptinezumab. It involved 160 Japanese patients with migraine who received the medicine for 60 weeks, followed by 8 weeks of safety monitoring. The main goal was to see how well patients tolera…

This early-stage study tested a new drug called Lu AF28996 in people with Parkinson's disease who experience 'off' periods where their regular medications wear off. The main goals were to check if the drug was safe, how well people could tolerate it, and how their bodies processe…

This large, completed study tested whether a medication called eptinezumab could help prevent migraines in adults who get them very frequently. Nearly 1,000 participants with chronic migraine received either the drug at one of two doses or a placebo injection to see which was bet…

This study tested if adding a preventive migraine drug called eptinezumab to a brief educational program helps adults who have frequent migraines and also overuse pain medications for headaches. Over 600 participants were randomly assigned to receive either eptinezumab or a place…

This study tested the safety of a new migraine injection (Lu AG09222) when taken with an existing oral migraine medication (ubrogepant). It involved 43 adults with a history of migraine to see if the combination caused any new or worsening side effects. This was an early-stage tr…